by Study Scavenger | Jan 22, 2019 | Study Scavenger Clinical Trial Recruitment Platform
– ADCT-601 uses a proprietary AXL antibody developed by BerGenBio and licensed to ADC Therapeutics for antibody drug conjugate (ADC) development – Phase I dose escalation and expansion trial will evaluate ADCT-601 in 75 cancer patients – ADCT-601 is...by Study Scavenger | Jan 22, 2019 | Study Scavenger Clinical Trial Recruitment Platform
The Center for Beta Cell Therapy in Diabetes, coordinator of an international consortium in translational medicine in diabetes, and ViaCyte, Inc., a privately held regenerative medicine company, today announced that a human stem cell-derived product candidate has been...by Study Scavenger | Jan 18, 2019 | Study Scavenger Clinical Trial Recruitment Platform
ImaginAb, Inc., an emerging immuno-oncology imaging company, announced today the enrollment of the first patient in the Phase II clinical trial of ImaginAb’s CD8+ T Cell imaging agent. The trial will enroll metastatic cancer patients and will study the...by Study Scavenger | Jan 18, 2019 | Study Scavenger Clinical Trial Recruitment Platform
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on novel, disease-modifying therapies for neurodegenerative diseases has announced its plans to initiate a Phase III trial to evaluate the efficacy of its lead drug, NB-01, in diabetic...by Study Scavenger | Jan 18, 2019 | Study Scavenger Clinical Trial Recruitment Platform
“It is with great satisfaction we can announce acceptance from the FDA and the Central Ethics Committee to initiate the Xplore trial. Applications to the additional countries are being submitted continuously during January and February. First patient in is...